Quasispecies changes with distinctive point mutations in the Hepatitis 

C virus internal ribosome entry site (IRES) derived from PBMCs and plasma by Mercuri, Luca et al.
Research Article
Quasispecies Changes with Distinctive Point Mutations in
the Hepatitis C Virus Internal Ribosome Entry Site (IRES)
Derived from PBMCs and Plasma
LucaMercuri ,1 Emma C. Thomson,2 Joseph Hughes,2 and Peter Karayiannis3
1Hepatology Section, Division of Medicine, Faculty of Medicine, Imperial College, London, UK
2University of Glasgow MRC Centre for Virus Research, Glasgow, UK
3University of Nicosia Medical School, Nicosia, Cyprus
Correspondence should be addressed to Luca Mercuri; luca.mercuri@nhs.net
Received 9 September 2018; Accepted 11 November 2018; Published 19 November 2018
Academic Editor: Amiya K. Banerjee
Copyright © 2018 Luca Mercuri et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The 5’ untranslated region (UTR) of the hepatitis C virus (HCV) genome contains the internal ribosome entry site (IRES), a
highly conserved RNA structure essential for cap-independent translation of the viral polyprotein. HCV, apart from the liver, is
thought to be associated with lymphocyte subpopulations of peripheral blood mononuclear cells (PBMCs), in lymph nodes and
brain tissue. In this study, RT-PCR, cloning, and sequence analysis were employed to investigate the quasispecies nature of the
5’UTR following extraction of viral RNA from PBMCs and plasma of HCV infected individuals. The nucleotide variation between
IRES-derived sequences from PBMCs and plasma indicated the existence of polymorphic sites within the IRES. HCV isolates
had divergent variants with unique mutations particularly at positions 107, 204, and 243 of the IRES. Most of the PBMC-derived
sequences contained anA-A-A variant at these positions.Themutations associatedwith the IRESes suggested the presence of unique
quasispecies populations in PBMCs compared with plasma.
1. Introduction
Hepatitis C virus (HCV), a member of the Hepacivirus genus
in the Flaviviridae family, is an enveloped virus with an
icosahedral capsid that encloses a single-stranded positive
sense genomic RNA of approximately 9.5 kb in length [1, 2].
The viral genome consists of a large open reading frame
(ORF) flanked by highly conserved untranslated regions
(UTR) present at the 5’ and 3’ termini [3]. The 5’end UTR,
which is 341 nt in length, contains an internal ribosome
entry site (IRES), a highly conserved region with extensive
secondary structure formed by palindromic complementary
sequences giving rise to four structural domains [4]. Research
into the structure and function of the IRES revealed that
its structure is required for the modulation of the cap-
independent IRES-mediated translation process by initially
recruiting cellular factors and ribosomal subunits [5]. HCV
is mainly hepatotropic, but its RNA has been associated with
lymph nodes, brain tissue, and peripheral blood mononu-
clear cells (PBMCs) especially macrophages, B-cells, and
T-cells (CD8+) [6, 7]. HCV replication has been reported
in fibroblasts, established human B cell lines (e.g., Rajii and
Daudi), T-cell lines (e.g., Molt-4 and Jurkat), and PBMC sub-
populations (CD4+, CD8+, and CD19+) from HCV infected
patients [8–11]. The presence of HCV RNA in extrahepatic
sites has also been detected in HCV infected individuals
where HCV negative strands (replicative intermediate) have
been associated with PBMCs, CD4+, CD8+, CD19+, T-cells,
monocytes, and macrophages [12]. In recent years, the virus
has been shown to persist in the PBMCs of patients who had
received successful antiviral treatment with Pegylated-IFN𝛼
(Peg-IFN𝛼) in combination with ribavirin. In such patients,
HCVRNAwas associated with PBMCs but not present in the
serum [13–15].
HCV RNA derived from PBMCs, liver tissue, and serum
samples from chronically infected patients has been shown
to display heterogeneity due to the presence of mutations in
the 5’UTR [16–18]. The presence of dominant quasispecies
with a restricted number of point mutations, distinct from
liver and serum, and identical nucleotide substitutions in
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the IRES region, such as the G107󳨀→A, C204󳨀→A and
G243󳨀→A, commonly known as the A-A-A variant detected
in patient derived cells have been previously detected also
in cell lines such as Daudi B cell lymphoblasts and human
T-cell lines [19]. This variant has been associated with lym-
phoid cell compartment infection [17] including monocyte-
derived dendritic cells [20], monocytes/macrophages [12]
and PBMCs [16]. Studies on IRES translational efficiency
indicated that theA-A-Avariant increased translation activity
in lymphoid cell lines compared to wild-type G-C-G variants
but not in cell lines derived from monocytes, granulocytes,
and hepatocytes [21]. IRES translation activity was greatly
enhanced in Raji, Bjab, and Molt4 but not in Jurkat cells,
hepatocytes (Huh-7), monocytes, and granulocyte cell lines
such as HL-60, KG-1, or THP-1 [21]. The A-A-A variant has
also been detected in the brain where the A204 and A243
mutations from HCV RNA present in the cerebellum were
absent from serum-derived HCV RNA of the same patient
suggesting that the CNS was a candidate site of extrahepatic
replication [17, 22, 23]. These studies have provided evi-
dence that there are nucleotide substitutions in the HCV
IRESes which are associated with lymphoid replication. The
aim of this study was to analyze the temporal changes of
HCV 5’UTR sequences obtained from PBMCs and compare
them with those obtained from plasma in HCV infected
patients. HCV RNA extraction, reverse transcription-PCR
(RT-PCR), cloning, sequence, and RNA structure analyses
were used to determine the presence of the A-A-A variant in
PBMCs.
2. Materials and Methods
2.1. Patient Samples. Blood samples were obtained from
twenty-four patients (all males, 24-62 years old) positive for
anti-HCV and HCV RNA by RT-PCR, who had abnormal
liver function tests for the first time since their last sched-
uled visit, suggesting acute infection with HCV (previously
negative). The patients were recruited into the St Mary’s
acute HCV cohort with inclusion criteria as previously
described [25]. None of the patients were coinfected with
Hepatitis B virus (HBV) or had other causes of liver disease.
The majority of patients were infected with HCV genotype
1a.
All work covering patient material was carried out fol-
lowing informed consent. Moreover, all such work received
approval from the Ethics committee at St. Mary’s Hospital.
2.2. RNA Extraction and RT-PCR. Blood samples were dilut-
ed with phosphate-buffered saline (PBS) (1:1), layered over
Ficoll Histopaque 1077 (Sigma-Aldrich), and centrifuged at
400g for 30 min at room temperature. The PBMC layer
was removed; the cells were washed twice with PBS and
sedimented twice at 100g for 10 min.
Viral RNA was extracted from plasma using a QIAmp
Viral RNA MiniKit (Qiagen) in accordance with the manu-
facturer’s instructions while total RNA was extracted from
PBMCs using the TRIzolreagent (Invitrogen). Genomic
DNA was removed from total RNA preparations by Turbo
DNA-freeDnase treatment (Ambion). Total RNAquality and
quantity were assessed on a NanoDrop ND-1000 spectropho-
tometer and analyzed on a 1% agarose gel to check size and
integrity. RNA was reverse-transcribed into complementary
DNA (cDNA) at 42∘C for 60 min using 0.5𝜇M of IRES-
specific antisense primer (5’-GCACGGTCTACGAGACCT-
3’) and 50 U of Moloney Murine Leukemia Virus reverse
transcriptase (MMLV RT) (RETROscript kit, Ambion) in
a volume of 20 𝜇l following the manufacturer’s protocol.
HCV 5’ UTR amplification was performed with the Fast
Start High Fidelity PCR System (Roche) to amplify a 243-
bp fragment from the HCV 5’UTR region. Primers used
were sense primer (5’-GCTTAGCCATGGCGTTAG-3’) and
antisense primer (5’-GCACGGTCTACGAGACCT-3’). A no
template control (NTC) and a no reverse transcriptase con-
trol (NRT) were included as negative controls to exclude
contamination.
PCR conditions were as follows: preamplification denat-
uration (one cycle), 95∘C for 2 min; amplification (35 cycles)
included denaturation at 95∘C for 30 sec, annealing at 56∘C
for 30 sec, and elongation at 72∘C for 40sec. A final elongation
step (1 cycle) was carried out at 72∘C for 7min. PCR products
were separated and visualized on a 2% agarose gel and
purified using the QIAquick Gel Extraction kit (Qiagen)
following the manufacturer’s protocol.
2.3. Cloning. Purified PCR products were ligated into the
pGEM-T Easy cloning vector (Promega) using T4 DNA
Ligase (3u/𝜇l) and transformed into competent Escherichia
coli DH5𝛼 cells (Invitrogen). A tube with no insert DNA
was included as negative control. Recombinant colonies were
detected by white/blue selection using 5-bromo-4-chloro-
3-indolyl-beta-D-galacto-pyranoside (X-Gal) (Promega) to
a final concentration of 40mg/ml and plasmid DNA was
extracted using the GenElute Plasmid Miniprep Kit (Sigma)
following the manufacturer’s protocol. Fifteen clones from
each of 15 plasma samples (n=225) and fifteen clones from
each of 15 PBMC samples (n=225) were sequenced with the
ABI3730xl analyzer (MRC CSC Genomics Core Laboratory,
London, United Kingdom).
2.4. Sequence Analysis. Sequence alignments and entropy
(Hx) calculations were performed using BioEdit software
(version 7.1.3) and the phylogenetic analysis by MEGA soft-
ware (version 5.1) using the Kimura 2-parameter model using
all the sequences obtained from the clones (PBMCs-derived
n=225, plasma-derived n=225).
As the majority of patients were infected with HCV
subtype 1a the genomic sequences of 438 HCV subtype 1a
isolates obtained from the Viral Bioinformatics Resource
Centre database and GenBank were aligned with BioEdit
software to align many HCV subtype 1a sequences in order
to determine the most commonly expressed nucleotide at
each position obtaining thus the best consensus sequence,
which was used for multiple sequence alignments of PBMC
and plasma-derived IRES amplicons. Additionally, the ΔG
was computed at 37∘C using the Turner model [23, 26] for
the RNA parameters with the RNAeval web server (http://
rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAeval.cgi).
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Figure 1: Nucleotide differences detected in 5’UTR sequences derived from patient PBMCs and plasma. Nucleotide changes in PBMC-
derived IRES sequences (n=225) are indicated in blue while nucleotide changes in plasma-derived IRES sequences (n=225) are indicated in
red. Similarities in nucleotide frequency variation between PBMCand plasma-derived samples are represented in green dots while differences
are represented in yellow dots. Structural domains are indicated in Roman letters (I-IV). The start codon AUG is highlighted in stem-loop
domain IV. Substitution sites are indicated as squares and arrows indicate mutations described in the text. Nucleotide sequence and putative
secondary RNA structure of the 5’UTR [nt. 1-383 genotype 1b (GenBank, AJ238799.1)] was adapted from Honda et al. [24].
3. Results
3.1. Sequence Variation between PBMC and Plasma Isolates.
The nucleotide differences among all the 225 sequences
derived from PBMC and all of the 225 sequences derived
from plasma samples are highlighted on the secondary
RNA structure of the 5’UTR HCV (nt. 1-383 genotype
1b (GenBank, AJ238799.1) where numbers indicate IRES
nucleotide positions relative to strain HCV 1a (GenBank,
NC 004102) (Figure 1). As the two-dimensional structure of
HCV genotype 1b 5’UTR was used as an outline to position
the nucleotide substitutions detected in HCV IRESes, mainly
genotype 1a (Figure 1), the HCV IRES genotype 1b was
aligned with consensus sequence genotype 1a to pinpoint any
differences between the two IRESes.Theonly differenceswere
substitutions 11U, 12G, 13A, 34G, 35A, 204A and 243Apresent
in genotype 1a (data not included).
PBMC-derived IRES sequences had more nucleotide
substitution sites than plasma-derived ones (27 versus 20).
Nucleotide substitutions present at positions 108, 113, 115,
124, 130, 198, 200, 216, 234, and 255, were only associated
with PBMC-derived IRESes. On the other hand, nucleotide
substitutions A152, G185, and A207 were only present in
plasma-derived IRESes. Nucleotide substitutions at positions
107, 119, 179, 183, 187, 204, 205, 210, 214, 220, 223, 224, 243,
247, 248, 262, and 270 were associated with both PBMC and
plasma-derived IRESes (Figure 1).
Nucleotide frequencies helped to identify the nucleotide
position where nucleotide frequency differences occurred
between PBMC and plasma-derived HCV IRESes. The
majority of the IRES motifs were conserved between PBMC
and plasma samples as similar nucleotide frequencies were
obtained along the IRES sequence. Nucleotide positions
179, 183, 187, 205, 210, 220, 223, 224, 234, 247, 248, 262,
and 270 (Figure 1, highlighted in green) contained two
nucleotide frequency changes common in both PBMC and
plasma-derived samples. However, positions 107, 119, 124, 152,
200, 204, 207, 214, 216, and 243 had different nucleotide
frequencies between PBMC and plasma-derived samples
(Figure 1, highlighted in yellow). Overall the majority of
changes occurred between nucleotide positions 179 to 187 and
200 to 224 and occasionally from 234 and 270.
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Figure 2: Entropy differences between the PBMC and plasma. Entropy differences between sequences (nt 100 to 300 of the HCV IRES)
derived from PBMCs (n=225) and plasma (n=225). Each bar represents the entropy difference at a single nucleotide position. Significant
differences between the entropy of PBMC and plasma are indicated by orange bars while no significant differences are indicated by blue bars.
The results were generated using a Perl script and the figure was produced in R software programming language.
3.2. Entropy Estimations between PBMC and Plasma Se-
quences. Entropy differences between PBMC and plasma-
derived IRESes were examined to quantify diversity in a
single nucleotide position (Figure 2). To calculate the entropy
differences between PBMCs- and plasma-derived IRESes, the
entropy dataset was randomised with replacement 100 times
and the difference in entropy was calculated for each of these
random sets. This difference was compared to the difference
between PBMC and plasma in the real set to determine
whether the difference in entropy was higher than you would
expect based on randomly sampling the sequences. A positive
value indicated that the entropy was higher in PBMC than
in plasma while a negative value indicated that the PBMC
had a lower entropy than the plasma. A significant entropy
difference according to the randomisation was associated
with specific nucleotide positions. High entropy in PBMCs
was detected at nucleotide positions 104, 108, 119, 124, 200,
205, 216, 221, 243, 245 and 282, while high entropy in plasma
(lower in PBMC), was detected at nucleotide positions 107,
152, 163, 207, 210, 211, 214, 220, 223, 224, 262 and 270
(Figure 2).
Conserved nucleotide sequences were identified among
PBMCs and plasma-derived IRES sequences. Two conserved
regions were identified in PBMC-derived IRES sequences
(131-CTCCCGGGAGAGCCATAGTGGTCTGCGGA ACC-
GGTGAGTACACCGGAA-178 and 271-GCGAAAGGC-
CTTGTGGTACTGCCTGATAGG-300). In plasma-derived
IRES sequences, five conserved regions were detected (120-
CCCCCCCTCCCGGGAGAGCCATAGTGGTCTGC-151,
153-GAACCGGTGAGTACACCGGAATTGCC-178, 188-
GGGTCCTTTCTTGGAT-203, 225-ATTTGGGCGTGC-
CCCCGC-242 and 271-GCGAAAGGCCTTGTGGTACTG-
CCTGATAGG-300). The numbering is based on the 1b
sequence with accession no. AJ238799.1.
3.3. Distribution of Quasispecies within Patients. In order
to determine in which compartment (PBMCs or plasma)
the distribution of each nucleotide combination at position
107, 204 and 243 was more variable, PBMC- and plasma-
derived samples were analyzed in each patient (Figure 3).
Plasma-derived samples hadmore variation in the population
of variants than PBMC-derived samples except in patient 3
and 7 where only one specific variant was present in plasma
samples. In each patient, the GAA and GAG variants were
present in plasma- but not in PBMC-derived samples.
3.4. Phylogenetic Analysis of the HCV IRES Population. The
sequence data obtained from all clones of PBMC- and
plasma-derived samples were used to construct an unrooted
phylogenetic tree (Figure 4), which revealed lineages con-
taining related PBMC- and plasma-derived HCV strains and
one distinctive lineage with isolated plasma-derived strains
(Figure 4(a)). A-A-A variants associated with PBMC and
plasma suggest possible selection (Figure 4(b)).
The effect of single point mutations on the thermody-
namic stability of the RNA was examined on the relevant
IRES domains (Figure 5). A decrease in ΔG indicated an
increase in stability of the relevant domain while an increase
in ΔG indicated a decrease in stability. Mutations G200A,
A204C, A214U, U216C, and G243A had no effect on the
stability of the RNA secondary structure. However,mutations
A107G, A108C in the IRES domain II and mutations A152G,
C207A, U262C, and U270C in the IRES domain III increased
the stability of the IRES structure. G200A and U216C were
only detected in PBMCs while G152A and C207A only in
plasma-derived IRESes (Figure 5).
4. Discussion
PBMC-derived samples had a much higher number of muta-
tions in domain II compared to plasma-derived samples (7
versus 2 mutations), particularly between nt 107 and 130
(Figure 1). Recent studies have shown that domain II induces
a conformational change of the 40S ribosomal subunit and
possibly holds the codingRNA into the decoding centre of the
ribosome during the assembly of the translation machinery
[27, 28]. Thus, it is possible that nucleotide substitution
C108A alone or in combination with G107A detected in
domain IImight influence initial steps that lead to translation
initiation in PBMCs. Mutation C108A, detected only in
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Figure 3: Distribution of nucleotide combinations at positions 107, 204, and 243 in PBMC- and plasma-derived IRES samples in different
patients. Data represent the frequencies in percent of all possible nucleotide combinations at positions 107, 204, and 243 detected in PBMC-
and plasma-derived HCV IRES samples from different patients.
PBMC-derived 5UTRs
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Figure 4: Phylogenetic tree analysis of all PBMC- and plasma-derived HCV IRES sequences.The evolutionary history was inferred by using
the Maximum Likelihood method based on the Kimura 2-parameter model. The tree with the highest log likelihood (-1129.7196) is shown.
Initial tree(s) for the heuristic search were obtained by applying the Neighbor-Joining method to a matrix of pairwise distances estimated
using the Maximum Composite Likelihood (MCL) approach. The tree is drawn to scale, with branch lengths measured in the number of
substitutions per site. The analysis involved 450 nucleotide sequences. PBMC-derived HCV IRES nucleotide sequences (n=225; coloured in
blue) and plasma-derived HCV IRES nucleotide sequences (n=225; coloured in red) (a). HCV IRESes with the triple adenine variant (A-A-A)
in PBMC (n=36; blue triangles) and in plasma (n=26; red triangles) (b). All positions containing gaps and missing data were eliminated.
There were a total of 200 positions (nt 100 to 300) in the final dataset.The bootstrap values along the branches indicate percent confidence of
branches. Bootstrap values greater than 70% are shown. The scale bar corresponds to 0.01 substitutions per site. Evolutionary analyses were
conducted in MEGA6.
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IRES region
Nt. 
Position
Mutation G G
Effect on G 
(kcal/mol)
Effect on G
G→A -23.7 -23.4 -0.3 Decreased
A→G -23.4 -23.7 0.3 Increased
C→A -23.7 -22.7 -1.0 Decreased
A→C -22.7 -23.7 1.0 Increased
U→C -23.7 -17.1 -6.6 Decreased
C→U -17.1 -23.7 6.6 Increased
G→A -47.5 -41.8 -5.7 Decreased
A→G -41.8 -47.5 5.7 Increased
G→A -47.5 -47.5 0.0 No effect
A→G -47.5 -47.5 0.0 No effect
A→C -47.5 -47.5 0.0 No effect
C→A -47.5 -47.5 0.0 No effect
C→A -47.5 -48.4 0.9 Increased
A→C -48.4 -47.5 -0.9 Decreased
A→U -47.5 -47.5 0.0 No effect
U→A -47.5 -47.5 0.0 No effect
U→C -47.5 -47.5 0.0 No effect
C→U -47.5 -47.5 0.0 No effect
A→G -47.5 -47.5 0.0 No effect
G→A -47.5 -47.5 0.0 No effect
C→A -54.9 -53.6 -1.3 Decreased
A→C -53.6 -54.9 1.3 Increased
U→C -54.9 -54.9 0.0 No effect
C→U -54.9 -54.9 0.0 No effect
U→C -54.9 -56.8 1.9 Increased
C→U -56.8 -54.9 -1.9 Decreased
C→U -54.9 -51.2 -3.7 Decreased
U→C -51.2 -54.9 3.7 Increased
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Figure 5: The effect of single point mutations on the thermodynamic stability of the relevant IRES domains. The thermodynamic stability
of the relevant domains was calculated using the RNAeval program with RNA free energy parameters and ΔG set at 37∘C. Blue cells indicate
mutations detected only in PBMC-derived IRESes while red cells indicate mutations detected only in plasma-derived IRESes.
PBMC-derived IRESes, may help HCV to possibly reduce
HCV translation and avoid immune detection.
Sequence variability wasmore pronounced in domain III,
particularly in the apical part, above a 4-way junction (IIIa,
b, and c), and between subdomains IIIc and IIId (Figure 1).
The apical part of domain III interacts with eIF3, the 40S
ribosomal subunit, and some transacting factors [29] and
might facilitate the recruitment of the ribosome to the IRES.
Sequence polymorphisms between nt 175 to 187 and nt 210
to 224 have also been detected in previous studies [30].
Additionally, the proximity of the 40S subunit to the helical
junction IIIabc of domain III might be the cause of the
concentration of substitutions in this IRES region, a region
that has an important role during the formation of the 48S
preinitiation complex and during the recruitment of the 43S
subunit and eIF3 [4]. Stem-loops IIIa and IIIc were conserved
among PBMCs and plasma-derived IRESes, except for a
single mutation in stem-loop IIIc at position 234 detected
only in PBMC-derived samples (Figure 1).
The distribution of nucleotide combinations at positions
107, 204, and 243 examined in each patient (Figure 3)
indicated that plasma samples were more diverse in the
population of variants than PBMC ones. These results may
be caused by a reduced exposure of the virus in PBMCs to
the immune system, passively evading its response. Thus, the
A-A-A variant which appeared to be the natural wild-type
for PBMCs might display a preferential tropism for these
cells and/or a more functional adaptation for translation in
these cells. A previous study has shown that low and high
translation variants with sequence changes in the IRES region
may be selected by the immune system [31].
The presence of PBMC variants not detected in plasma
of the same patient, and therefore derived from his/her liver,
may indicate provenance from replication in PBMCs or other
extrahepatic sites or may represent stored HCV RNA from
past quasispecies no longer present in plasma, or may be
caused by selection of viral variants in or associated with
PBMCs.
Significant entropy differences according to the ran-
domisation between PBMC- and plasma-derived sequences
(Figure 2) indicated high entropy in PBMCs (nt positions
104, 108, 119, 124, 200, 205, 216, 221, 243, 245, and 282)
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and high entropy in plasma (nt positions 107, 152, 163, 207,
210, 211, 214, 220, 223, 224, 262, and 270). These significant
differences between the entropy of the PBMC and the
plasma indicate nucleotide diversity at these specific positions
suggesting possible selection and virus diversity in each
position.
Significant differences with high entropy values were
located in domain II in PBMCs and only on the right side
of the predicted IRES domain III. On the other hand, the
high entropy in plasma concerned only position 107 in IRES
domain II and both sides of domain III, in particular domain
IIIb and domain IIId, which are involved in the binding
of eIF3a and the 40S ribosomal subunit [32]. This suggests
selective pressure in these regions and the relation of entropy
changes with IRES activity. Regarding nt positions 107, 204,
and 243, the entropy was higher only in plasma at positions
107 and 243 while no significant differences occurred at
position 204 (Figure 2).
Phylogenetic analysis of all PBMC- and plasma-derived
IRES sequences (Figure 4) suggested that, on the whole,
PBMC-derived IRESes were the most divergent variants with
the longest branch lengths and appeared to have originated
from plasma. Additionally, the tree suggested a nonrandom
distribution of PBMC- and plasma-derived IRESes. The
phylogenetic tree suggested that the A-A-A variant possibly
changed and/or derived from plasma. However, more data
is required to understand the relationship of the different
phylogenetic polytomies.
Future analysis with chemical and enzymatic probing
will be critical for validating and interpreting RNA structure
or modelling. Overall, the results in this study suggest that
the IRES is subject to more modifications in PBMCs than
in plasma as a larger number of mutations were identified
only in PBMC-derived IRESes. It is possible that some of
the different mutations associated with PBMCs and plasma
may relate to the origin of the released virus particles,
which could be from liver or lymphocytes, and based on the
mutations acquired may allow viral replication or inhibition
in extrahepatic sites. This hypothesis could also explain the
minor variants associated with each population from the
cloning study. Previous studies on HCV infection of B-
cells indicated that, during chronic infection, B-cells and/or
monocytes frequently harboured specific HCV variants
[33].
Two conserved IRES regionswere associatedwith PBMC-
derived IRESes and five in plasma-derived IRESes. Some
of these regions are located in ribosomal binding sites as
previously reported [34]. The conserved region between nt
271 to 300 was common in both PBMC- and plasma-derived
IRESes as this region is essential for binding to the 40S sub-
unit [35]. This region contains subdomain IIId, an essential
component of the HCV IRES, as previous studies have shown
that mutations within domain IIId disrupted IRES-mediated
initiation caused by the structural reorganization of the HCV
IRES leading to reduced IRES activity [32, 36]. PBMC-
derived samples had more mutations in domain IIId than
in plasma-derived IRESes suggesting a possible reduction in
IRES activity by the acquired mutations in domain IIId in
PBMCs.
The analysis of the effect of the examined mutations on
the thermodynamic stability of the IRES indicated that few
mutations in IRES domains II and III (Figure 5) increased
or decreased IRES stability. Single point mutations detected
only in plasma-derived IRESes at positions 152, 207 and 270
affected the predicted IRES structure and thermodynamic
stability (Figure 5). Nucleotide substitution C270U is located
in a region (nt 277 to 295) known to be essential for binding to
40S subunits [35]. It is possible that the effect of one mutation
on IRES stability might be counteracted by the occurrence
of another mutation. For example the effect of A107G and/or
A108C might be counteracted by the effect of G107A and/or
C108A together or in combination (Figure 5). The IRES may
acquire a single point mutation, as C207A was detected only
in plasma-derived IRESes to decrease the thermodynamic
stability of the IRES and thus possibly reduce viral translation
in plasma or acquire mutations such as G107A, G152A and
C207A to increase IRES stability and possibly increase viral
translation.
The thermodynamic stability values may not predict
the affinity of RNA binding to ribosomal subunits but it
is possible that the IRES stability might affect HCV repli-
cation. Thus, HCV might acquire mutations to decrease
the thermodynamic stability of the IRES and to control its
replication while present in immunoprivileged sites. This
might explain the different disease outcomes among HCV
patients. It is possible that the identified mutations may
occur during the life cycle of the virus under certain cel-
lular environmental conditions and that the location of the
point mutations on the IRES may disrupt IRES function
or reduce translation efficiency as seen in previous studies
[17, 21, 37]. Additionally, populations with acquired muta-
tions may increase over time resulting in long-term clinical
consequences.
5. Conclusions
In conclusion, these results of the study suggest that the
quasispecies dynamics are a mechanism through which
HCV is able to adapt to its host environment through
IRES diversity, possibly to regulate translational activity and
tropism in different cells. The mutations and regions of
similarities identified in this study may be a consequence of
functional, structural, or evolutionary relationships between
IRES sequences, which may influence the binding of cellular
factors and may reduce or increase translation efficiency
accordingly. The results raise the possibility that these strains
may compete through the efficiency of the IRES, as previous
studies showed plasma IRESes to be more competent than B
cell IRESes in hepatocytes indicating a selective pressure on
extra-hepatic strains and, therefore, extra-hepatic replication
[38]. HCV variants might have a selective advantage in
immunoprivileged sites and allow the persistence of the
virus in these sites without immune detection as previously
suggested [20]. This could explain why nucleotide substitu-
tions occurred more often in PBMCs than in plasma-derived
samples.
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